Lobe Sciences Ltd.
Lobe Sciences Ltd. (LOBE.CN) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Lobe Sciences Ltd. (LOBE.CN), featuring income statements, balance sheets, and cash flow data.
Lobe Sciences Ltd. (LOBE.CN) Income Statement & Financial Overview
Analyze Lobe Sciences Ltd.’s LOBE.CN earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $28236.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | -$28236.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $12923.00 | $7551.00 | $1024.00 | $179875.00 |
| SG&A Expenses | $621348.00 | $634434.00 | $388551.00 | $415472.00 |
| Operating Expenses | $634271.00 | $641985.00 | $0.00 | $590355.00 |
| Total Costs & Expenses | $634271.00 | $641985.00 | $389577.00 | $590355.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $134507.00 | $123164.00 | $105462.00 | $36596.00 |
| Depreciation & Amortization | $21177.00 | $21177.00 | $0.00 | $28236.00 |
| EBITDA | -$569000.00 | -$677000.00 | -$2.69M | -$362000.00 |
| EBITDA Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$634000.00 | -$642000.00 | -$390000.00 | -$590000.00 |
| Operating Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | -$68757.00 | -$159000.00 | -$2.41M | $163553.00 |
| Income Before Tax | -$703000.00 | -$801000.00 | -$2.80M | -$427000.00 |
| Income Before Tax Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | $0.00 | $0.00 | $33000.00 | $0.00 |
| Net Income | -$703000.00 | -$801000.00 | -$2.83M | -$427000.00 |
| Net Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS | -$0.004 | -$0.005 | -$0.02 | -$0.003 |
| Diluted EPS | -$0.004 | -$0.005 | -$0.02 | -$0.003 |
| Weighted Avg Shares Outstanding | $186.37M | $173.70M | $122.13M | $158.77M |
| Weighted Avg Shares Outstanding (Diluted) | $186.37M | $173.70M | $122.13M | $158.77M |
Over the last four quarters, Lobe Sciences Ltd.'s revenue moved from $0.00 in Q3 2024 to $0.00 in Q2 2025. Operating income in Q2 2025 was -$634000.00, with a strong operating margin of N/A. Despite fluctuations in R&D and SG&A expenses, EBITDA for Lobe Sciences Ltd. remained robust at -$569000.00, reflecting operational efficiency. Net income rose to -$703000.00, with an EPS of -$0.004. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan